Skip to main content
. Author manuscript; available in PMC: 2011 Jun 23.
Published in final edited form as: Pediatr Cardiol. 2010 Oct 21;32(1):1–7. doi: 10.1007/s00246-010-9795-5

Table 5.

Graft outcome

Variable High-dose group Low-dose group
In-hospital mortality 10/22 (45%) 2/32 (6.3%)
Retransplantation 3/12 (25%) 7/30 (23%)
Out-of-hospital mortality 0/12 (0%) 9/30 (30%)
Graft survival at 6 months 41% 44%
Mean follow-up 5.8 years (2.2–9.6 years) 4.4 years (1.4–8.6 years)
Development of new/progression of TCAD 1 patient—continued graft survival 8 patients—all died before 6 months